AJANTPHARM.BOAJANTPHARM.BOBSE
Loading
EBITDA Margin Over TimeStable
Percentile Rank29
3Y CAGR-5.0%
5Y CAGR-1.9%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-5.0%/yr
vs -1.0%/yr prior
5Y CAGR
-1.9%/yr
Recent deceleration
Acceleration
-4.0pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineStable
PeriodValueYoY Change
202527.29%-8.6%
202429.86%+26.8%
202323.55%-26.0%
202231.80%-11.6%
202135.97%+19.5%
202030.10%+3.3%
201929.14%-12.1%
201833.14%-10.6%
201737.09%+4.5%
201635.48%-